Top 10 Companies in the (S)-4‑phenyl‑2‑oxazolidinone (CAS 99395‑88‑7) Market (2026): Market Leaders Powering Global Supply

MARKET INSIGHTS

Global (S)-4‑phenyl‑2‑oxazolidinone (CAS 99395‑88‑7) market was valued at USD 187.4 million in 2025. The market is projected to grow from USD 198.6 million in 2026 to USD 364.2 million by 2034, reflecting a compound annual growth rate of 7.8 % over the forecast period.

(S)-4‑phenyl‑2‑oxazolidinone is a chiral oxazolidinone auxiliary that delivers high enantioselectivity in asymmetric synthesis. The compound is used to construct complex molecules for pharmaceutical intermediates, agrochemical active ingredients, and fine‑chemical intermediates where precise stereochemical control is essential.

Demand is sustained by the expansion of enantiopure active pharmaceutical ingredients (APIs) and the growing adoption of asymmetric synthesis across the pharmaceutical sector. Investments in process chemistry and the need for cost‑efficient chiral building blocks further reinforce market expansion. Leading suppliers include Sigma‑Aldrich (Merck KGaA), TCI Chemicals, and Thermo Fisher Scientific.

(S)-4‑phenyl‑2‑oxazolidinone (CAS 99395‑88‑7) Market – View in Detailed Research Report

Top 10 Companies

1. TCI Chemicals (Tokyo Chemical Industry Co., Ltd.)
   Headquarters: Tokyo, Japan
   Key Offering: Comprehensive catalog of chiral reagents, including pharmaceutical‑grade (S)-4‑phenyl‑2‑oxazolidinone

   TCI leverages its global distribution network to supply high‑purity chiral auxiliaries to pharmaceutical, agrochemical, and fine‑chemical manufacturers. The company invests in analytical capabilities to maintain stringent enantiomeric purity standards.

   • Expansion of GMP‑qualified production lines
   • Strategic partnerships with CDMOs in Asia‑Pacific
   • Commitment to ISO 9001 and ICH compliance
2. MilliporeSigma (Sigma‑Aldrich / Merck KGaA)
   Headquarters: Darmstadt, Germany / St. Louis, USA
   Key Offering: Global supply of high‑purity chiral auxiliaries and reagents for pharmaceutical development

   MilliporeSigma’s integrated R&D and manufacturing capabilities enable rapid scale‑up of chiral building blocks. The firm maintains a robust quality management system that aligns with ICH Q7 guidelines.

   • Investment in chiral resolution technologies
   • Support for early‑stage discovery programs
   • Focus on sustainability through reduced solvent usage
3. Thermo Fisher Scientific
   Headquarters: Waltham, USA
   Key Offering: Broad portfolio of specialty chemicals, including chiral auxiliaries for pharmaceutical synthesis

   Thermo Fisher combines its analytical expertise with a global supply chain to deliver consistent quality for pharmaceutical clients.

   • Development of high‑throughput chiral screening platforms
   • Collaboration with academic research institutes
   • Commitment to green chemistry initiatives
4. Jinan Haohua Industry Co., Ltd.
   Headquarters: Jinan, China
   Key Offering: Production of chiral intermediates for pharmaceutical and agrochemical applications

   Jinan Haohua has scaled its production to meet the growing demand from domestic and international markets.

   • Expansion of production capacity to 5 k g/year
   • Adoption of continuous flow synthesis for chiral resolution
   • Strengthening of quality assurance protocols
5. Hangzhou Dayangchem Co., Ltd.
   Headquarters: Hangzhou, China
   Key Offering: Specialty chiral reagents for fine‑chemical manufacturing

   Dayangchem focuses on delivering high‑purity chiral auxiliaries to the pharmaceutical sector.

   • Implementation of GMP‑compliant facilities
   • Partnerships with leading CDMOs in China
   • Continuous improvement of enantiomeric purity
6. Fluorochem Ltd.
   Headquarters: Cambridge, United Kingdom
   Key Offering: Custom synthesis of chiral compounds and intermediates

   Fluorochem’s expertise in fluorinated chiral molecules supports advanced pharmaceutical research.

   • Expansion of specialty chemical services
   • Investment in chiral HPLC infrastructure
   • Collaboration with academic research groups
7. Combi‑Blocks Inc.
   Headquarters: New York, USA
   Key Offering: Research‑grade chiral reagents and custom synthesis services

   Combi‑Blocks serves the academic and early‑stage R&D market with high‑quality chiral auxiliaries.

   • Development of modular synthesis kits
   • Support for medicinal chemistry programs
   • Focus on rapid turnaround times
8. AK Scientific Inc.
   Headquarters: Boston, USA
   Key Offering: High‑purity chiral reagents for pharmaceutical development

   AK Scientific offers a range of chiral auxiliaries with stringent purity controls.

   • Investment in analytical instrumentation
   • Partnerships with CROs for custom synthesis
   • Commitment to sustainable laboratory practices
9. Nanjing Chemlin Chemical Industry Co., Ltd.
   Headquarters: Nanjing, China
   Key Offering: Production of specialty chiral intermediates for pharmaceuticals and agrochemicals

   Chemlin focuses on scalable production and quality assurance.

   • Implementation of GMP‑qualified processes
   • Expansion of chiral resolution capacity
   • Collaboration with global supply chains
10. Alfa Aesar
    Headquarters: Haverhill, USA
    Key Offering: Specialty chemicals and chiral reagents for research and industry

    Alfa Aesar supplies a broad range of chiral auxiliaries with robust quality documentation.

    • Expansion of research‑grade offerings
    • Investment in analytical services
    • Support for green chemistry initiatives

Download FREE Sample Report

Get Full Report

Outlook

Over the next decade, the (S)-4‑phenyl‑2‑oxazolidinone market is expected to maintain a steady trajectory driven by the ongoing development of chiral APIs and the increasing preference for single‑enantiomer drugs. The shift toward greener manufacturing processes and the rise of CDMOs in emerging economies will further shape procurement patterns.

Future Trends

• Adoption of catalytic asymmetric synthesis to complement stoichiometric chiral auxiliaries.
• Growth of agrochemical demand for enantiopure pesticides and herbicides.
• Expansion of chiral liquid‑crystal and polymer applications in advanced materials.
• Increased focus on supply‑chain resilience and local manufacturing capabilities.